Dr. Galaznik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
33 Arch Street
Boston, MA 02110- Is this information wrong?
Education & Training
Weill Cornell MedicineClass of 2005
Publications & Presentations
PubMed
- 11 citationsEconomic Burden of Patients Treated for Higher-Risk Myelodysplastic Syndromes (HR-MDS) in Routine Clinical Care in the United StatesJill A Bell, Aaron Galaznik, Marlo Blazer, Huai-Che Shih, Eileen Farrelly, Augustina Ogbonnaya, Michael Eaddy, Robert J. Fram, Douglas V. Faller> ;Pharmacoeconomics - Open. 2019 Jun 1
- 3 citationsMeta-analytical methods for estimating outcomes from overall response rate in patients with relapsed/refractory diffuse large B-cell lymphoma.Ling Wang, Hung Lam, Yaping Shou, Aaron Galaznik> ;Oncotarget. 2019 May 14
- 4 citationsPredicting Outcomes in Patients With Diffuse Large B-Cell Lymphoma Treated With Standard of Care.Aaron Galaznik, Christian G. Reich, Greg Klebanov, Yuriy Khoma, Eldar Allakhverdiiev, Greg Hather, Yaping Shou> ;Cancer Informatics. 2019 Mar 15
- Join now to see all
Press Mentions
Oncology and Technology: Improving the Lives of Cancer Patients Through Better OutcomesMarch 26th, 2022- Carevive Appoints Aaron Galaznik, M.D. As Chief Scientific OfficerFebruary 15th, 2022
- Medidata Thought Leaders Discuss the Future of Clinical Trials at 2021 SCOPE Annual MeetingMarch 1st, 2021
- Join now to see all
Professional Memberships
- International Society for Pharmacoeconomics and Outcomes ResearchMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
